← Evidence map

ArticleLeukemia & lymphoma2017

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

Adebayo Ogunniyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 27735212